Effect of Hashimoto Disease in Diabetic Patients in National Center for Diabetes | ||
| Engineering and Technology Journal | ||
| Article 6, Volume 37, 3B, December 2019, Pages 99-103 PDF (742.23 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.30684/etj.37.3B.6 | ||
| Authors | ||
| Aufaira S. Nsaif1; Wafaa R. Alfatlawi2; Abdulnasser M. ALgobori2 | ||
| 1National Center for Diabetes, AL-Mustansiriyah University - Iraq | ||
| 2Department of Applied Science, University of Technology - Iraq | ||
| Abstract | ||
| The most two common autoimmune disease in endocrinology was Diabetes mellitus (DM) and thyroid dysfunction (TD). This study aimed to investigate the prevalence of TD in DM patients of type 1. The current study is carried out in the National Center for Diabetes of Endocrine and Genetic (NCDEG), AL- Mustansiriyah University, Baghdad. This study comprised of (36) patients with hypothyroidism diagnosed clinically under supervision of specialist physician in endocrinology. Their ages ranged between (30-40) years, among them there were 17 males (48%) and 19 females (52%). In addition there were (36) healthy control their age ranged between (28-42) years, among them there were 21 males (58%) and 15 females (42%). Results showed highly significant increase in the rate of Chol, TSH, T3, and FBS in patient group when compared with healthy subject (p<0.001), also highly significant decrease of T4 (p<0.001). The prevalence of thyroid dysfunction among type 1 DM patients is very high with hypothyroidism is being most common. This study recommended that screening of thyroid function must be done especially in uncontrolled diabetic patients. | ||
| Keywords | ||
| Type I Diabetes Mellitus; Hashimoto disease; Thyroid hormones | ||
| References | ||
|
[1] S. Shanmugam, S. Damodharan, T. Jacob, “Prevalence of thyroid dysfunction in patients with diabetes mellitus,” Int J Res Med Sci.; Vol. 3, No. 12, 3629-3633, 2015. [2] A. Khurana, P. Dhoat,and G.Jain “Prevalence of thyroid disorders in patients of type 2 diabetes mellitus,” JIACM; Vol. 17, No. 1, 12-15, 2016. [3] E. McCanlies, A. O’ Leary, T. Foley, M. Kaye, and P. Burke “Hashimoto’s Thyroiditis and InsulinDependent Diabetes Mellitus: Differences among Individuals with and without Abnormal Thyroid Function,” The Journal of Clinical Endocrinology & Metabolism, Vol. 83, Issue 5, 1548–1551, 1998. [4] C. Wang, “The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases,” J Diabetes Res., Published online Apr 4 2013. [5] J. Garber, R. Cobin, H. Gharib, and J. Hennessey, “Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association,” Endocr Pract, Vol. 18, No. 6, 988-1028, 2012. [6] P. Caturegli, A. De Remigis, and N.R. Rose, “Hashimoto thyroiditis: Clinical and diagnostic criteria,” Autoimmunity ReviewsVol. 13, Issues 4–5, 391-397, 2014. [7] R. Abdulmahdi Mohsin, Thesis, “'Detection of Prediabetes in Hypothyroidism Iraqi Patients,” 2014. [8] P. Raghuwanshi, D. Pratap, and B. Kumar, “Evaluation of thyroid dysfunction among type 2 diabetic patients,” Asian Journal of Medical Sciences, Vol. 6, No. 3, 2015. [9] R. Swamy, N. Kumar1, and K. Srinivasa, “Evaluation of hypothyroidism as a complication in Type II Diabetes Mellitus,” Biomedical Research; Vol. 23, No. 2, 170-172, 2012. [10] V. Witting, D. Bergis, and D. Sadet, “Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study,” Thyroid Res.; Vol. 7, No. 2, 2014. [11] H. Abdi, E. Kazemian, S. Gharibzadeh, and A. Amouzegar, “Association between Thyroid Function and Body Mass Index: A 10-Year Follow-Up,” Ann Nutr Metab, Vol. 70, No. 4, 338-345, 2017. [12] N. Chary, K. Pindicura and D. Sreedhar, “Developmental Anomalies of Thyroid Gland, FNAC Based Study, In a Tertiary Care Hospital for Head and Neck Diseases,” Sch. J. App. Med. Sci.; 4, 6A, 1936- 1939, 2016. [13] D. Greef, J. Rondeel, and V. Haasteren, “Regulation of hypothalamic TRH production and release in the rat,” Acta Med Austriaca, 9 Suppl 1, 77- 9, 1992. [14] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), “Hashimoto's Disease,” article, 2017. [15] F. Monaco, “Classification of Thyroid Diseases: Suggestions for a Revision,” The Journal of Clinical Endocrinology & Metabolism, Volume 88, Issue 4, Pages 1428–1432, 2003. [16] S. Mushtaq, S. Ishaq, and T. Rashid, “DYSLIPIDEMIA IN THYROID DISORDERS,” Indo American Journal of Pharmaceutical Research, ISSN NO: 2231-6876, 2015. [17] Q. Bayar, S. Arif, anhd A. Mohammed, “Dyslipidemia in Subclinical Hypothyroidism: A Case-Control Study,” J. Endocrinol Diab, 5, 1, 1-6., 2018. [18] G. Brenta, and O. Fretes, “Dyslipidemias and hypothyroidism,” Pediatr Endocrinol Rev. Jun, 11, 4, 390-9, 2014. [19] M. Peppa, G. Betsi, and G. Dimitriadis, “Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease” Journal of Lipids, Vol. Article ID 575840, 9 pages, 2011. [20] G.A. Brent, “Mechanisms of thyroid hormone action,” J Clin Invest. Sep 4; 122, 9, 3035–3043, 2012. [21] Harvard Medical School, http://www.health.harvard.edu/E, “Thyroid disease: Understanding hypothyroidism and hyperthyroidism,” 2007. | ||
|
Statistics Article View: 221 PDF Download: 189 |
||